Aigen Investment Management’s Evolent Health EVH Stock Holding History

Aigen Investment Management’s Portfolio EVH Stock Details EVH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$33.9K	Buy	+14,850	New	+$47.1K	0.01%	495
2025 Q4	–	Sell	-54,701	Closed	-$463K	–	707
2025 Q3	$463K	Buy	+54,701	New	+$531K	0.07%	416
2023 Q2	–	Sell	-21,381	Closed	-$694K	–	814
2023 Q1	$694K	Buy	+21,381	New	+$676K	0.1%	254
2022 Q4	–	Sell	-35,759	Closed	-$1.28M	–	607
2022 Q3	$1.28M	Buy	+35,759	New	+$1.26M	0.18%	161
2022 Q2	–	Sell	-9,671	Closed	-$312K	–	587
2022 Q1	$312K	Buy	+9,671	New	+$253K	0.05%	361
2020 Q4	–	Sell	-40,603	Closed	-$504K	–	848
2020 Q3	$504K	Buy	+40,603	New	+$477K	0.06%	396

Other funds holding EVH

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

CCM

Cadian Capital Management New York $821M AUM 14.36% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Rubicon Founders Nashville, Tennessee $138M AUM 61.96% 1-Year Est. Return

Engaged Capital Newport Beach, California $303M AUM 2.09% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

RSCM

Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Aigen Investment Management's EVH Position: Q1 2026 in Review

Aigen Investment Management opened a new position in Evolent Health (EVH) in Q1 2026: 14,850 shares worth $33.9K. The stake represents 0.01% of the portfolio and ranks #495 among its holdings. This is a return to the name: Aigen Investment Management previously reported a position in EVH as recently as Q3 2025.

Aigen Investment Management first reported a position in EVH in Q3 2020 and has held it in 6 quarters since. The position peaked at $1.28M in Q3 2022. 191 funds tracked by Wall St. Rank hold EVH as of Q1 2026.

Aigen Investment Management held 14,850 shares of Evolent Health worth $33.9K as of Q1 2026.
Evolent Health was a new Aigen Investment Management position in Q1 2026.
Evolent Health made up 0.01% of Aigen Investment Management's portfolio in Q1 2026, its #495 holding.
Aigen Investment Management first reported a position in Evolent Health in Q3 2020 and has held it in 6 quarters since.
Aigen Investment Management's Evolent Health position peaked at $1.28M in Q3 2022.
191 funds tracked by Wall St. Rank held Evolent Health as of Q1 2026.

Based on Aigen Investment Management's 13F filing for Q1 2026, filed 15 May 2026.